194673-12-6

Usage

Uses

Used in Pharmaceutical Synthesis:
Ethyl 6-oxo-2-(trifluoromethyl)-1,4,5,6-tetrahydropyridine-3-carboxylate is used as a building block in the pharmaceutical industry for the synthesis of various drugs. Its unique structure and functional groups make it a valuable component in the development of new medicinal compounds with specific therapeutic properties.
Used in Agrochemical Synthesis:
In the agrochemical industry, ethyl 6-oxo-2-(trifluoromethyl)-1,4,5,6-tetrahydropyridine-3-carboxylate is utilized as a key intermediate in the synthesis of agrochemicals, such as pesticides and herbicides. Its incorporation into these products can enhance their effectiveness and selectivity in controlling pests and weeds.
Used in Organic Chemical Reactions:
Ethyl 6-oxo-2-(trifluoromethyl)-1,4,5,6-tetrahydropyridine-3-carboxylate is employed as a reagent in various organic chemical reactions, including the formation of new chemical bonds, functional group transformations, and the synthesis of complex organic molecules. Its versatility and reactivity make it a valuable tool in organic chemistry research and development.

Upstream product

• 79-06-1 2-propenamide 
• 372-31-6 ethyl 4,4,4-trifluoroacetoacetate 
• 814-68-6 acryloyl chloride 
• 372-29-2 ethyl 3-amino-4,4,4-trifluoro-2-butenoate 

Downstream Products

• 1268245-17-5 3-(2-(6-((5-cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl)methoxy)-2-(trifluoromethyl)pyridin-3-yl)cyclopropyl)benzoic acid 
• 1245614-20-3 C₂₀H₁₃Cl₂F₃N₂O₃ 
• 1245614-10-1 C₂₀H₁₅Cl₂F₃N₂O₃ 
• 1245614-08-7 C₂₂H₁₇Cl₂F₃N₂O₄ 
• 676993-98-9 6-(3-chloro-phenylamino)-N-(pyridin-4-ylmethyl)-2-trifluoromethyl-nicotinamide 
• 676627-04-6 6-(3-chloro-phenylamino)-2-trifluoromethyl-nicotinic acid hydrochloride 
• 676627-03-5 6-(3-chloro-phenylamino)-2-trifluoromethyl-nicotinic acid ethyl ester 
• 261635-82-9 ethyl 6-chloro-2-(trifluoromethyl)pyridine-3-carboxylate 

Relevant academic research and scientific papers

COMPOUNDS THAT MODULATES AMPA RECEPTOR FUNCTION

The invention provides compounds of the formula (I): (I) wherein A1, A2, R2, R4, B1, B2, X, X1, n, a and b are as defined are defined in the specification, to pharmaceutical comp

NOVEL FXR (NR1H4 ) BINDING AND ACTIVITY MODULATING COMPOUNDS

The present invention relates to compounds which bind to the NR1 H4 receptor (FXR) and act as agonists of the NR1 H4 receptor (FXR). The invention further relates to the use of the compounds for the preparation of a medicament for the treatment of diseases and/or conditions through binding of said nuclear receptor by said compounds, and to a process for the synthesis of said compounds.

2-TRIFLUOROMETHYLNICOTINAMIDE DERIVATIVES AS HDL-CHOLESTEROL RAISING AGENTS

The present invention relates to compounds formula I: and pharmaceutically acceptable salts thereof, wherein R1 to R8 are as defined in the description and claims for use as HDL-cholesterol raising agents in the treatment and/or prop

COMBINATION OF CB2 MODULATORS AND PDE4 INHIBITORS FOR USE IN MEDICINE

Combination of one or more CB2 modulators such as a compound of formula (I), (II) and (III); and one more PDE4 inhibitors are useful of treating conditions which are mediated by the activity of CB2 receptors or conditions which are mediated by PDE4, such

PYRIDINE DERIVATIVES AS CB2 RECEPTOR MODULATORS

The present invention relates to novel pyridine derivatives, pharmaceutical compositions containing these compounds and their use in the treatment of diseases, particularly pain, which diseases are caused directly or indirectly by an increase or decrease

PYRIDINE DERIVATIVES AS CB2 RECEPTOR MODULATORS

The present invention relates to novel pyridine derivatives of formula (I) pharmaceutical compositions containing these compounds and their use in the treatment of diseases, particularly pain, which diseases are caused directly or indirectly by an increas